San Francisco, June 21st, 2017 – Recardio Inc. today announced that it has appointed its newly formed Scientific Advisory Board, reflecting the company’s entering the clinical phase 2 development in 2017.
Recardio receives FDA Clearance
San Francisco, March 27th, 2017 – Recardio Inc. Receives FDA Clearance of IND in Regenerative Therapy Program.
- « Previous Page
- 1
- …
- 3
- 4
- 5